Effects of fenoterol on the skeletal system depend on the androgen level

Leszek Śliwiński1, Urszula Cegieła1, Maria Pytlik1

  • 1Department of Pharmacology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Katowice, Poland.

Abstract

Insights

Fenoterol, a sympathetic nervous system drug, damaged bone in normal rats but protected against bone loss in testosterone-deficient rats, highlighting its complex role in bone remodeling.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Bone Biology

Background:

  • The sympathetic nervous system's role in bone remodeling remains incompletely understood.
  • Investigating the impact of beta-2 adrenergic agonists on skeletal health is crucial.

Purpose of the Study:

  • To investigate the effects of fenoterol on bone microarchitecture and remodeling.
  • To determine fenoterol's impact in both normal and androgen-deficient states.
  • To elucidate the drug's mechanism in osteoclastogenesis.

Main Methods:

  • In vivo studies using normal and orchidectomized rats treated with fenoterol.
  • In vitro investigation of osteoclastogenesis and mRNA expression in mouse osteoblast cell cultures.
  • Analysis of bone microarchitecture and cellular responses.

Main Results:

  • Fenoterol impaired bone microarchitecture in rats with normal androgen levels.
  • In androgen-deficient rats, fenoterol mitigated osteoporosis-related bone damage.
  • In vitro, fenoterol promoted osteoclastogenesis with testosterone but inhibited it without testosterone.

Conclusions:

  • Fenoterol exhibits a dual effect on bone: detrimental in the presence of androgens and protective in their absence.
  • These findings underscore the sympathetic nervous system's significant role in regulating bone remodeling.
  • Fenoterol's differential effects suggest potential therapeutic applications in specific hormonal conditions.

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.9K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.8K
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
1.8K
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.9K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K